About
Small Molecule for Alzheimer's
Areas of Focus
Categories
Small Molecule PharmaceuticalAustralia
Team (22)
A/Prof Christopher Chen
Actinogen Medical
team_member
Andrew (Andy) Udell (he/him)
Actinogen Medical
team_member
Cheryl Townsend (she/her)
Actinogen Medical
team_member
Dr Christina Kurre Olsen
Actinogen Medical
team_member
Dr Dana C. Hilt
Actinogen Medical
team_member
Dr Elizabeth Berry-Kravis
Actinogen Medical
team_member
Clinical Trials (14)
View allTotal Trials
14
As Lead Sponsor
6
As Collaborator
8
Total Enrollment
129,362
By Phase
PHASE2: 3PHASE1/PHASE2: 1PHASE1: 2
By Status
COMPLETED: 9RECRUITING: 2UNKNOWN: 2WITHDRAWN: 1
Clinical Trials Pipeline14 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06125951Lead Sponsor
Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease
PHASE2Recruiting
220 participants
Started: Apr 12, 2024 · Completed: Dec 31, 2025
NCT05657691Lead Sponsor
Xanamem® in Adults With Major Depressive Disorder and Impaired Cognition (XanaCIDD)
PHASE2Completed
167 participants
Started: Nov 28, 2022 · Completed: Jul 1, 2024
NCT03158857Collaborator
Hepatitis C Treatment Study in Myanmar
N/AWithdrawn
Started: Jan 31, 2022 · Completed: Jan 31, 2024
NCT04478578Collaborator
Incidences, Causes, and Outcomes of Febrile Illness in Rural South and Southeast Asia
N/ARecruiting
100,000 participants
Started: Aug 4, 2021 · Completed: Dec 30, 2024
NCT04983368Lead Sponsor
A Double-Blind, Placebo-Controlled, Dose Ranging Study of Xanamem® in Healthy Elderly Volunteers
PHASE1/PHASE2Completed
107 participants
Started: Jun 30, 2021 · Completed: Feb 11, 2022
Locations (1)
Headquarters
West Perth, Australia
Map
Loading map...